#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune demyelinating disease B-cell lymphoma refractory Chronic granulomatous disease Andersen-Tawil syndrome Congenital pseudarthrosis Prolymphocytic leukaemia Peripheral primitive neuroectodermal tumour of soft tissue Glioma Extranodal marginal zone B-cell lymphoma (MALT type) Meningitis meningococcal Immune-mediated myositis B-cell type acute leukaemia Systemic candida Transitional cell carcinoma Astrocytoma More trials…

    Learn about Rare Diseases

    Toxic epidermal necrolysis – Diagnostics Sarcoma Rhabdomyosarcoma recurrent – Diagnostics Cytokine release syndrome – Trials in Disease Hypereosinophilic syndrome – Basic Information Advanced systemic mastocytosis – Treatment Epidermolysis bullosa Piriformis syndrome – Treatment Hereditary motor and sensory neuropathy – Diagnostics Ocular melanoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Migalastat Thiotepa Linsitinib R2R01 Tofacitinib Ticagrelor Ly3871801 Tabelecleucel Cendakimab Prax-628 Levothyroxine Sodium PROMESTRIENE Ivabradine Hydrochloride Mva-209-Fsp-B3 Iron Sucrose Imipenem Monohydrate Quc398 Acetylsalicylic Acid Ph. Eur. Donidalorsen SOFOSBUVIR More therapies…

    Learn about Your Condition

    Paresis Transient ischaemic attack Asplenia Herpes simplex meningitis Soft tissue sarcoma T-cell type acute leukaemia Malformation venous Addison's disease Erythema multiforme Post procedural complication Systemic candida Neuropathy peripheral Neurodegenerative disorder Oesophageal cancer metastatic Phaeochromocytoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of semaglutide and finerenone for kidney and blood vessel protection in adults with chronic kidney disease, with or without diabetes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Finerenone
    • Semaglutide
    Denmark

  • Study of Flumazenil to Reduce Side Effects of Electroconvulsive Therapy in Patients with Depression

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Depression
    Denmark

  • Study of personalized tamoxifen dosing (10mg, 20mg, or 40mg daily) compared to standard dose (20mg) in women with breast cancer to improve treatment continuation

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Tamoxifen
    Sweden

  • Study on the Effects of Ertugliflozin and Semaglutide on Heart Health in Patients with Type 2 Diabetes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Canagliflozin
    • Ertugliflozin
    • Insulin Aspart
    Italy

  • Study of zanidatamab in adult patients with HER2-positive solid tumors (endometrial, colorectal, head & neck, sarcoma) or HER2-mutant non-small cell lung cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • HER2 mutant non-small cell lung cancer
    • Sarcoma
    • Head and neck cancer
    Investigated Drugs:
    • Zanidatamab
    France

  • Study evaluating blood biomarkers for diagnosis and monitoring treatment in patients with pulmonary tuberculosis using isoniazid, rifampicin, pyrazinamide, and ethambutol combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia bacterial
    • Pulmonary tuberculosis
    Investigated Drugs:
    • Ethambutol Hydrochloride
    • Isoniazid
    • Pyrazinamide
    Spain
Previous Page
1 … 165 166 167 168 169 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!